Tomorrow also means medication on the Pharmaceutical Benefits Scheme will drop to its lowest point in 2 decades. For millions of Australians without a concession card, it'll only cost as much as 25 dollars, pharmacists believing it will ease the strain on regional hospitals. #7NewsCentralWest #pbs #medications | 7NEWS Central West

From 1 January 2026, Pharmaceutical Benefits Scheme (PBS) medicines will be capped at $25, down from $31.60, while pensioners will continue paying $7.70 until 2030. The price reduction returns PBS prescription costs to 2004 levels and will benefit 400,000 Australians weekly, with particular improvements for women's health medications including contraception and hormone replacement therapy, as well as treatments for cancer, diabetes and arthritis. The measure aims to address medication affordabil

56K views · 34 reactions | Simplefill Prescription Assistance Programs offers a cost-saving solution to patients who enroll in the program. Maya Lovlien from Simplefill discusses how the fulfillment advocates efficiently handle refills, re-enrollments and troubleshoot any problems that may arise for the patients and caregivers. Simplefill specialists look at each patient’s situation as unique, reaching the best option for that particular person. | Access Health | Facebook

The Pharmaceutical Benefits Scheme is now in the sights of Donald Trump who is threatening a 250 per cent tariff. But Anthony Albanese says making medicines cheaper for those in need is 'part of who we are', adamant that it is not up for negotiation. 📱Download the 7NEWS app: 7news.link/7newsapp #7NEWS | 7NEWS Melbourne

7.9K views · 57 reactions | A new drug, which greatly extends the life of patients with incurable blood cancer multiple myeloma has been added to the pharmaceutical benefits scheme. It means the life-changing therapy, now more than $160,000 a year, will soon be available at virtually no cost. www.7NEWS.com.au #7NEWS | 7NEWS Brisbane | Facebook

100K views · 1.3K reactions | US medical giants call Australia’s Pharmaceutical Benefits Scheme “unfair trade practice”. Will Australian leaders stand up to Donald Trump’s tariff threats? Catch up on Q+A on iview. | Q+A | Facebook